Healthcare provider profile · identity verified

Natercia Rodrigues, MD

Family Practice · ROCHESTER, NY · NPI 1417246521

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	375	87
Levothyroxine Sodium	Levothyroxine Sodium	270	59
Amlodipine Besylate	Amlodipine Besylate	249	57
Famotidine	Famotidine	225	47
Gabapentin	Gabapentin	207	42
Metformin Hcl Er	Metformin Hcl	203	39
Ozempic	Semaglutide	159	27
Lisinopril	Lisinopril	157	41
Rosuvastatin Calcium	Rosuvastatin Calcium	154	38
Pantoprazole Sodium	Pantoprazole Sodium	142	24
Omeprazole	Omeprazole	141	44
Escitalopram Oxalate	Escitalopram Oxalate	130	24
Losartan Potassium	Losartan Potassium	124	31
Bupropion Xl	Bupropion Hcl	94	22
Fluticasone Propionate	Fluticasone Propionate	92	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	91	28
Hydrochlorothiazide	Hydrochlorothiazide	91	25
Trazodone Hcl	Trazodone Hcl	90	21
Duloxetine Hcl	Duloxetine Hcl	88	20
Pregabalin	Pregabalin	86	19
Metoprolol Succinate	Metoprolol Succinate	80	28
Hydroxyzine Hcl	Hydroxyzine Hcl	64	23
Albuterol Sulfate Hfa	Albuterol Sulfate	63	24
Carvedilol	Carvedilol	57	16
Venlafaxine Hcl Er	Venlafaxine Hcl	57	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	54	suppressed
Alendronate Sodium	Alendronate Sodium	53	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	53	11
Simvastatin	Simvastatin	52	13
Metoprolol Tartrate	Metoprolol Tartrate	50	suppressed
Buspirone Hcl	Buspirone Hcl	48	suppressed
Metformin Hcl	Metformin Hcl	47	14
Mirtazapine	Mirtazapine	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	suppressed
Ibuprofen	Ibuprofen	43	16
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Topiramate	Topiramate	41	suppressed
Montelukast Sodium	Montelukast Sodium	39	suppressed
Mounjaro	Tirzepatide	37	11
Eliquis	Apixaban	36	suppressed
Meloxicam	Meloxicam	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Jardiance	Empagliflozin	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	15
Diazepam	Diazepam	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Torsemide	Torsemide	30	suppressed
Aripiprazole	Aripiprazole	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Prazosin Hcl	Prazosin Hcl	28	suppressed
Arnuity Ellipta	Fluticasone Furoate	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	12
Single Use Swab	Alcohol Antiseptic Pads	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Olanzapine	Olanzapine	25	suppressed
Latanoprost	Latanoprost	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Nystatin	Nystatin	23	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Varenicline Tartrate	Varenicline Tartrate	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Valsartan	Valsartan	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Prednisone	Prednisone	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Norethindrone Acetate	Norethindrone Acetate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Atenolol	Atenolol	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Finasteride	Finasteride	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error